Acuitas Therapeutics

Headquarters

6190 Agronomy Road, Suite 405 Vancouver, BC, V6T 1Z3

Email: info@acuitastx.com
Facebook: @Acuitas
Twitter: @Acuitastx
linkedin.com/acuitastx
Acuitas: (noun) insight, perception, sharpness.

TECHNOLOGY

PARTNERING

FEATURED NEWS

NEWS: COVID-19 VACCINE RECEIVES HEALTH CANADA APPROVAL (DEC 2020)

The BioNTech (with Pfizer) COVID-19 vaccine that uses our lipid nanoparticle delivery system technology has received emergency use authorization by Health Canada. Read about it here.

NEWS: COVID-19 VACCINE WITH CUREVAC (NOV 2020)

Biotech firm CureVac is using Acuitas Therapeutics’ lipid nanoparticles as part of their COVID-19 vaccine. CureVac announced positive results in their clinical studies. Read about it here.

PUBLICATION: SCIENCEDIRECT - D614G SPIKE MUTATION INCREASES SARS CoV-2 SUSCEPTIBILITY TO NEUTRALIZATION (DEC 2020)

We are honoured that our collaboration with Dr. Weissman in the development of D614G spike mutation that increases SARS CoV-2 susceptibility to neutralization has been published by Cell Host Microbe. You can find it here.